PROCEDURE FOR STRUCTURAL CHARACTERIZATION OF A RECOMBINANT POLYCLONAL PROTEIN OR A POLYCLONAL CELL LINE
Patent №
US 8,288,109
Granted
2012-10-16
Filed 2007
Owner
SYMPHOGEN A/S
Lab
—
AI components
1
hardware
Assignment
Recorded
Dataset
AIPD
2023_r1 edition
Application
11658021
The present invention provides a structural characterization platform that can be used to assess the stability of a polyclonal cell line during production, as well as batch-to-batch consistency of the final polyclonal products. The structural characterization platform is based on genetic analyses as well as protein characterization techniques that alone or in combination provide the necessary information to characterize the polyclonal cell line and final products. The collection of different homologous proteins to be analyzed with the platform techniques if for example a recombinant polyclonal antibody or a mixture of monoclonal antibodies.
AI classification
Ownership
SYMPHOGEN A/S
assignment · 191770949
Assignors
RASMUSSEN, LONE KJAER, FRANDSEN, TORBEN, RASMUSSEN, SOREN KOFOED, ANDERSEN, PETER SEJER
On an employer assignment, the assignors are typically the inventors.